Purchase Order HT001416P0882
Award Date
4/6/16
Potential Completion Date
4/15/16
Potential Value
$17K
Federal Agency
Defense Health Agency
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Valencia, CA 91355, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The contract, valued at $14,480.01, is for the FMRT-1-25-US AMNISURE ROM TEST. The award does not indicate any set-aside designation. Qiagen has previously provided a range of products and services to support federal biomedical research, public health, law enforcement, and healthcare programs under prime and subcontracts with agencies such...
The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
Qiagen, LLC was awarded a $17,393.80 firm fixed price delivery order by the Defense Health Agency to provide TEST KITS. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. No set-aside designation was applied to this award. Performance will take place in Germantown, Maryland through September 30, 2024. Qiagen holds several indefinite delivery contracts with federal agencies including...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
This is a $10,397.51 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international firm Qiagen N.V. The contract is for the provision of medical supplies, with a period of performance through September 30, 2023. Qiagen has provided a range of products and services supporting federal biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, sequencing equipment, and bioinformatics software. The...
The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Qiagen, LLC, a division of the international medical diagnostics company Qiagen N.V. The contract, valued at $80,457.60, is for the supply of various QIAGEN laboratory supplies including DNA/RNA extraction kits, PCR reagents, and related equipment. This contract was awarded under an unrestricted solicitation and did not have a set-aside designation. Qiagen, as a manufacturer of these specialized...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Qiagen, LLC for a reagent kit needed to sequence libraries. The contract has a ceiling value of $22,607.27 and a completion date of September 30, 2024. Qiagen is a division of the international provider Qiagen N.V. and has extensive experience supporting federal agencies' biomedical research, public health, and healthcare programs through past prime and subcontract awards....
Qiagen, LLC has been awarded a $20,551.32 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of the Army Medical Command in Germantown, Maryland. The contract calls for Qiagen to provide its MIRCURY LNA MIRNA FOCUS PCR Panel, which is used to support the Medical Command's medical research and healthcare programs. No subcontractors or set-aside designations were identified. Qiagen, LLC is a subsidiary of Qiagen N.V., an international...
This is a $107,508 firm fixed-price purchase order contract awarded by the Department of the Navy's Bureau of Medicine and Surgery to Qiagen, LLC, a division of Qiagen N.V., for the provision of laboratory reagents for testing. The contract has a period of performance ending on November 1, 2016 and was awarded on May 1, 2016. Qiagen is a global provider of sample and assay technologies and has a history of providing products and services to support federal agencies' biomedical research, public...